Pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy—case report

Malignant mesothelioma is an aggressive cancer associated with prior exposure to asbestos and dismal prognosis. Immune checkpoint inhibitor therapy is currently approved by the Food and Drug Administration for pre-treated malignant pleural mesothelioma. We describe a 75-year-old patient with dissemi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Transl Lung Cancer Res
Asıl Yazarlar: Schiopu, Sanziana R. I., Käsmann, Lukas, Schönermarck, Ulf, Fischereder, Michael, Grabmaier, Ulrich, Manapov, Farkhad, Rauch, Josefine, Orban, Martin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AME Publishing Company 2021
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7947381/
https://ncbi.nlm.nih.gov/pubmed/33718042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-1095
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller